DOI: http://dx.doi.org/10.18203/2394-6040.ijcmph20213664

Demographic and KAP determinants of COVID-19 vaccine hesitancy and vaccine refusal: a cross-sectional study in Indian population

Meghna Gupta, Rohit Goyal, Shruti Aggarwal, Mansunderbir Singh, Vitull K. Gupta, Nikita Garg

Abstract


Background: Recent rise in vaccine non-acceptance is a threat to global health, especially with the ongoing   COVID-19 pandemic. Examining the intentions of the Indian population towards the COVID-19 vaccine and the determinants of vaccine hesitancy and vaccine refusal is of utmost importance.

Methods: We conducted a cross-sectional web-based anonymous survey, using pre-validated questionnaires. Demographic and knowledge, attitude, and practice characteristics were collected, and a binary logistic regression was applied to analyse the association between these characteristics and the participants’ intention to for the COVID-19 vaccine. Reasons for vaccine non-acceptance were then determined using a pre-validated vaccine hesitancy questionnaire.

Results: Out of the 1172 non-vaccinated participants, 190 (16.2%) refused vaccination, and 219 (18.6%) were hesitant. Adequate knowledge about the COVID-19 disease, made people less likely to be hesitant for vaccination (OR=0.39; 95% CI=0.27-0.57), and less likely to refuse it (OR=0.41; 95% CI=0.27-0.61). Females had a higher tendency to refuse the vaccination (OR=1.47; 95% CI=1.02-2.14), or to be hesitant for it (OR=1.80; 95% CI=1.29-2.52). Social media played an important role in decreasing vaccination refusal (OR=0.40; 95% CI=0.22-0.73), when compared to evidence-based literature.

Conclusions: Knowledge about the COVID-19 disease can help people make a more informed decision towards vaccination, and social media can be utilised as a medium to address the gaps in knowledge of the Indian population.


Keywords


COVID-19, KAP, India, Survey, Vaccine hesitancy, Vaccine refusal

Full Text:

PDF

References


World Health Organization. Timeline of response to COVID-19. World Health Organization’s COVID-19 response. 2020. Available at: https://www.who. int/emergencies/diseases/novel-coronavirus-2019/interactive-timeline. Accessed on 27 May 2021.

World Health Organization. WHO Coronavirus (COVID-19) Dashboard With Vaccination Data. World Health Organization’s COVID-19 response. Available at: https://covid19.who.int/. Accessed on 05 August 2021.

Qualls N, Levitt A, Kanade N, Wright-Jegede N, Dopson S, Biggerstaff M, et al. Community mitigation guidelines to prevent pandemic influenza - United States, 2017. MMWR Recomm Reports. 2017;66(1):1–34.

Eyal N, Lipsitch M, Smith PG. Human challenge studies to accelerate coronavirus vaccine licensure. J Infect Dis. 2021 May 11;221:1752–6.

World Health Organization. Ten threats to global health in 2019. Geneva Switzerland.. World Health Organisation (WHO). 2019: 1–18. Available at: https://www.who.int/news-room/spotlight/ten-threats-to-global-health-in-2019. Accessed on 05 August 2021.

MacDonald NE, Eskola J, Liang X, Chaudhuri M, Dube E, Gellin B, et al. Vaccine hesitancy: Definition, scope and determinants. Vaccine. 2015;33:4161–4.

Yang Y, Dobalian A, Ward KD. COVID-19 Vaccine Hesitancy and Its Determinants Among Adults with a History of Tobacco or Marijuana Use. J Community Health. 2021;1-9.

Lazarus J V., Ratzan SC, Palayew A, Gostin LO, Larson HJ, Rabin K, et al. A global survey of potential acceptance of a COVID-19 vaccine. Nat Med. 2021;27:225–8.

Josephine S Christy, Kaur K, Gurnani B, Olivia M Hess, Narendran K, Venugopal A et al. Knowledge, attitude and practise toward COVID-19 among patients presenting to five tertiary eye care hospitals in South India - A multicentre questionnaire-based survey. Indian J Ophthalmol. 2020;68:2385–90.

Al-Qerem WA, Jarab AS. COVID-19 Vaccination Acceptance and Its Associated Factors Among a Middle Eastern Population. Front Public Heal. 2021;9:34.

NCIRD. Certain Medical Conditions and Risk for Severe COVID-19 Illness. Centers for Diseases Control. 2020. Available at: https://www.cdc.gov/ coronavirus/2019-ncov/need-extra-precautions/people-with-medical-conditions.html. Accessed on 05 August 2021.

Olum R, Chekwech G, Wekha G, Nassozi DR, Bongomin F. Coronavirus Disease-2019: Knowledge, Attitude, and Practices of Health Care Workers at Makerere University Teaching Hospitals, Uganda. Front Public Heal. 2020;8:181.

Dowdy D, D’Souza G. What is Herd Immunity and How Can We Achieve It With COVID-19? - COVID-19 - Johns Hopkins Bloomberg School of Public Health. John Hopkins Public Health. 2021. Available at: https://www.jhsph.edu/covid-19/articles/achieving-herd-immunity-with-covid19.html. Accessed on 05 August 2021.

Patel M, Lee AD, Clemmons NS, Redd SB, Poser S, Blog D, et al. National Update on Measles Cases and Outbreaks — United States, January 1–October 1, 2019. MMWR Morb Mortal Wkly Rep. 2019;68(40):893–6.

Sutton RM, Douglas KM. Agreeing to disagree: Reports of the popularity of Covid-19 conspiracy theories are greatly exaggerated. Psychological Medicine. Cambridge University Press; 2020: 1–3.

Dror AA, Eisenbach N, Taiber S, Morozov NG, Mizrachi M, Zigron A, et al. Vaccine hesitancy: the next challenge in the fight against COVID-19. Eur J Epidemiol. 2020;35:775–9.

Neumann-Böhme S, Varghese NE, Sabat I, Barros PP, Brouwer W, van Exel J, et al. Once we have it, will we use it? A European survey on willingness to be vaccinated against COVID-19. Eur J Heal Econ. 2020;21:977–82.

Wang J, Jing R, Lai X, Zhang H, Lyu Y, Knoll MD, et al. Acceptance of covid-19 vaccination during the covid-19 pandemic in china. Vaccines. 2020;8(3):482.

Galbadage T, Peterson BM, Awada J, Buck AS, Ramirez DA, Wilson J, et al. Systematic review and meta-analysis of sex-specific COVID-19 clinical outcomes. Front Med. 2020;7:348.

Robertson E, Reeve KS, Niedzwiedz CL, Moore J, Blake M, Green M, et al. Predictors of COVID-19 vaccine hesitancy in the UK household longitudinal study. Brain Behav Immun. 2021;94:41–50.

Fisher KA, Bloomstone SJ, Walder J, Crawford S, Fouayzi H, Mazor KM. Attitudes Toward a Potential SARS-CoV-2 Vaccine : A Survey of U.S. Adults. Ann Intern Med. 2020;173(12):964-73.

Seale H, Heywood AE, Leask J, Sheel M, Durrheim DN, Bolsewicz K, et al. Examining Australian public perceptions and behaviors towards a future COVID-19 vaccine. BMC Infect Dis. 2021;21:120.

Reiter PL, Pennell ML, Katz ML. Acceptability of a COVID-19 vaccine among adults in the United States: How many people would get vaccinated? Vaccine. 2020;38(42):6500–7.

Thaker J. The Persistence of Vaccine Hesitancy: COVID-19 Vaccination Intention in New Zealand. J Health Commun. 2021;26(2):104–11.

Verger P, Dubé E. Restoring confidence in vaccines in the COVID-19 era. Expert Rev Vaccines. 2020;19(11):991–3.

Kumari A, Ranjan P, Chopra S, Kaur D, Kaur T. Knowledge, barriers and facilitators regarding COVID-19 vaccine and vaccination programme among the general population: A crosssectional survey from one thousand two hundred and forty-nine participants. Diabetes Metab Syndr Clin Res Rev. 2021;15(3):987–92.